131 related articles for article (PubMed ID: 21094816)
1. Hyperuricemia in kidney transplant recipients with intact graft function.
Kim KM; Kim SS; Han DJ; Yang WS; Park JS; Park SK
Transplant Proc; 2010 Nov; 42(9):3562-7. PubMed ID: 21094816
[TBL] [Abstract][Full Text] [Related]
2. Hyperuricemia in adult renal allograft recipients: prevalence and predictors.
Malheiro J; Almeida M; Fonseca I; Martins LS; Pedroso S; Dias L; Henriques AC; Cabrita A
Transplant Proc; 2012 Oct; 44(8):2369-72. PubMed ID: 23026595
[TBL] [Abstract][Full Text] [Related]
3. Elderly renal transplant recipients and renal dysfunction: a risk factor for hyperuricemia.
Einollahi B; Einollahi H; Rostami Z
Exp Clin Transplant; 2011 Dec; 9(6):376-80. PubMed ID: 22142044
[TBL] [Abstract][Full Text] [Related]
4. Uric acid contributes to glomerular filtration rate deterioration in renal transplantation.
Kim KM; Kim SS; Yun S; Lee MS; Han DJ; Yang WS; Park JS; Park SK
Nephron Clin Pract; 2011; 118(2):c136-42. PubMed ID: 21150221
[TBL] [Abstract][Full Text] [Related]
5. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk.
Bandukwala F; Huang M; Zaltzman JS; Nash MM; Prasad GV
Am J Cardiol; 2009 Mar; 103(6):867-71. PubMed ID: 19268747
[TBL] [Abstract][Full Text] [Related]
6. High levels of uric acid correlate with decline of glomerular filtration rate in chronic kidney disease.
Satirapoj B; Supasyndh O; Nata N; Phulsuksombuti D; Utennam D; Kanjanakul I; Choovichian P; Duangurai K
J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S65-70. PubMed ID: 21280518
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of early-onset hyperuricemia in renal transplant recipients.
Chung BH; Kang SH; Hwang HS; Choi BS; Park CW; Kim YS; Kim JI; Moon IS; Yang CW
Nephron Clin Pract; 2011; 117(3):c276-83. PubMed ID: 20847570
[TBL] [Abstract][Full Text] [Related]
8. Effect of allopurinol on slowing allograft functional decline in kidney transplant recipients.
Osadchuk L; Bashir MH; Tangirala B; Marcus RJ; Nashar K; Hussain SM; Sureshkumar KK
Exp Clin Transplant; 2014 Jun; 12(3):190-4. PubMed ID: 24907717
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
Zhu X; Chen J; Han F; Cheng M; Xu L; Zhang L; Ding X; Le Y
Transplant Proc; 2009 Nov; 41(9):3736-42. PubMed ID: 19917377
[TBL] [Abstract][Full Text] [Related]
10. Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome.
Min SI; Yun IJ; Kang JM; Park YJ; Min SK; Ahn C; Kim SJ; Ha J
Nephrol Dial Transplant; 2009 Aug; 24(8):2584-90. PubMed ID: 19395726
[TBL] [Abstract][Full Text] [Related]
11. Effects of hyperuricemia on renal function in pediatric renal transplant recipients.
Fidan C; Kantar A; Baskın E; Gülleroğlu K; Akdur A; Moray G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():247-50. PubMed ID: 25894164
[TBL] [Abstract][Full Text] [Related]
12. Association of serum phosphorus level with anemia in kidney transplant recipients.
Kovesdy CP; Mucsi I; Czira ME; Rudas A; Ujszaszi A; Rosivall L; Kim SJ; Wolf M; Molnar MZ
Transplantation; 2011 Apr; 91(8):875-82. PubMed ID: 21358369
[TBL] [Abstract][Full Text] [Related]
13. Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy.
Akalin E; Ganeshan SV; Winston J; Muntner P
Transplantation; 2008 Sep; 86(5):652-8. PubMed ID: 18791445
[TBL] [Abstract][Full Text] [Related]
14. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients.
Karbowska A; Boratynska M; Kusztal M; Klinger M
Transplant Proc; 2009 Oct; 41(8):3052-5. PubMed ID: 19857674
[TBL] [Abstract][Full Text] [Related]
15. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH
J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754
[TBL] [Abstract][Full Text] [Related]
16. Role of uric acid in post-renal transplantation hypertension.
Bandukwala F; Huang M; Prasad GV
Transplant Proc; 2009 Jun; 41(5):1634-6. PubMed ID: 19545696
[TBL] [Abstract][Full Text] [Related]
17. Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival.
Numakura K; Satoh S; Tsuchiya N; Saito M; Maita S; Obara T; Tsuruta H; Inoue T; Narita S; Horikawa Y; Kagaya H; Miura M; Habuchi T
Transplantation; 2012 Jul; 94(2):145-51. PubMed ID: 22728291
[TBL] [Abstract][Full Text] [Related]
18. Hyperuricemia in pediatric renal transplant recipients.
Uslu Gokceoglu A; Akman S; Koyun M; Comak E; Dogan CS; Akbas H; Dinckan A
Exp Clin Transplant; 2013 Dec; 11(6):489-93. PubMed ID: 24344940
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors of Hyperuricemia After Renal Transplantation and Its Long-term Effects on Graft Functions.
Eyupoglu S; Eyupoglu D; Kendi-Celebi Z; Akturk S; Tuzuner A; Keven K; Sengul S
Transplant Proc; 2017 Apr; 49(3):505-508. PubMed ID: 28340822
[TBL] [Abstract][Full Text] [Related]
20. Hyperuricemia after renal transplantation.
Kalantar E; Khalili N; Hossieni MS; Rostami Z; Einollahi B
Transplant Proc; 2011 Mar; 43(2):584-5. PubMed ID: 21440768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
